comparemela.com

Supernus Announces Promising Interim Data from Ongoing Open-Label Phase 2a Study of SPN-817 in Epilepsy

Supernus Announces Promising Interim Data from Ongoing Open-Label Phase 2a Study of SPN-817 in Epilepsy
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Timothyc Dec ,Peter Vozzo ,Jack Khattar ,Jacka Khattar ,Drug Administration ,Supernus Pharmaceuticals Inc ,Supernus Pharmaceuticals ,Exchange Commission ,Company Investor Relations ,Nasdaq ,Securities Exchange ,Announces Promising Interim Data ,Ongoing Open Label Phase ,Investor Relations ,Orphan Drug ,Dravet Syndrome ,Lennox Gastaut Syndrome ,Percent Change ,Clinical Global Impression Severity ,Private Securities Litigation Reform Act ,Securities Exchange Act ,Senior Vice President ,

comparemela.com © 2020. All Rights Reserved.